Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod279

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod279
Module size 38 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
10349

ABCA10 ATP binding cassette subfamily A member 10
26154

ABCA12 ATP binding cassette subfamily A member 12
154664

ABCA13 ATP binding cassette subfamily A member 13
23461

ABCA5 ATP binding cassette subfamily A member 5
23460

ABCA6 ATP binding cassette subfamily A member 6
10351

ABCA8 ATP binding cassette subfamily A member 8
10350

ABCA9 ATP binding cassette subfamily A member 9
23456

ABCB10 ATP binding cassette subfamily B member 10
23457

ABCB9 ATP binding cassette subfamily B member 9
4363

ABCC1 ATP binding cassette subfamily C member 1
89845

ABCC10 ATP binding cassette subfamily C member 10
85320

ABCC11 ATP binding cassette subfamily C member 11
94160

ABCC12 ATP binding cassette subfamily C member 12
8714

ABCC3 ATP binding cassette subfamily C member 3
10257

ABCC4 ATP binding cassette subfamily C member 4
10057

ABCC5 ATP binding cassette subfamily C member 5
368

ABCC6 ATP binding cassette subfamily C member 6
6833

ABCC8 ATP binding cassette subfamily C member 8
10060

ABCC9 ATP binding cassette subfamily C member 9
9429

ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group)
64240

ABCG5 ATP binding cassette subfamily G member 5
64241

ABCG8 ATP binding cassette subfamily G member 8
358

AQP1 aquaporin 1 (Colton blood group)
89872

AQP10 aquaporin 10
359

AQP2 aquaporin 2
360

AQP3 aquaporin 3 (Gill blood group)
361

AQP4 aquaporin 4
362

AQP5 aquaporin 5
363

AQP6 aquaporin 6
364

AQP7 aquaporin 7
343

AQP8 aquaporin 8
364

AQP9 aquaporin 7
9843

HEPH hephaestin
341208

HEPHL1 hephaestin like 1
25240

MIP aquaporin 1
54020

SLC37A1 solute carrier family 37 member 1
23541

TAP1 SEC14 like lipid binding 2
266629

TAP2 SEC14 like lipid binding 3

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
5.30e-01 9.76e-29 Reactome Passive transport by Aquaporins

Transport of small molecules
3.37e-01 4.44e-55 GO ATPase activity, coupled to transmembrane movement of substances

molecular_function
2.23e-01 1.17e-20 GO ATPase-coupled anion transmembrane transporter activity

molecular_function
1.04e-01 3.96e-26 GO water transport

biological_process
9.52e-02 2.04e-11 GO glycerol channel activity

molecular_function
5.52e-02 4.28e-20 GO ATP hydrolysis coupled anion transmembrane transport

biological_process
4.42e-02 1.70e-04 GO ferroxidase activity

molecular_function
6.92e-03 7.11e-05 GO vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane

biological_process
2.37e-03 7.55e-15 GO excretion

biological_process
4.49e-04 2.85e-05 Reactome ATP sensitive Potassium channels

Neuronal System

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
0e+00 0e+00 lipid localization

0e+00 0e+00 excretion

0e+00 0e+00 lipid transport

0e+00 0e+00 anion transport

0e+00 0e+00 fluid transport

0e+00 0e+00 water transport

0e+00 0e+00 glycerol transport

0e+00 0e+00 polyol transport

0e+00 0e+00 inorganic anion transport

0e+00 0e+00 anion transmembrane transport

0e+00 0e+00 ATP hydrolysis coupled transmembrane transport

0e+00 0e+00 ATP hydrolysis coupled anion transmembrane transport

0e+00 0e+00 basolateral plasma membrane

0e+00 0e+00 ATPase activity

0e+00 0e+00 ATPase activity, coupled to transmembrane movement of substances

0e+00 0e+00 ATPase activity, coupled to movement of substances

0e+00 0e+00 nucleoside-triphosphatase activity

0e+00 0e+00 hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances

0e+00 0e+00 ATPase activity, coupled

0e+00 0e+00 water transmembrane transporter activity


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
0.00e+00 0.00e+00 TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES
0.00e+00 0.00e+00 ABC FAMILY PROTEINS MEDIATED TRANSPORT
0.00e+00 0.00e+00 AQUAPORIN MEDIATED TRANSPORT
0.00e+00 0.00e+00 PASSIVE TRANSPORT BY AQUAPORINS
0.00e+00 0.00e+00 ABC FAMILY PROTEINS MEDIATED TRANSPORT
0.00e+00 0.00e+00 AQUAPORIN MEDIATED TRANSPORT
0.00e+00 0.00e+00 PASSIVE TRANSPORT BY AQUAPORINS
2.35e-09 7.36e-07 ABCA TRANSPORTERS IN LIPID HOMEOSTASIS
4.14e-09 9.42e-07 ABCA TRANSPORTERS IN LIPID HOMEOSTASIS
6.29e-07 1.13e-04 REGULATION OF WATER BALANCE BY RENAL AQUAPORINS
7.18e-07 1.65e-04 REGULATION OF WATER BALANCE BY RENAL AQUAPORINS
2.63e-04 3.04e-02 ER PHAGOSOME PATHWAY
3.39e-04 3.83e-02 ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC
4.70e-04 5.13e-02 INWARDLY RECTIFYING K CHANNELS
5.63e-04 7.15e-02 ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC
1.01e-03 1.19e-01 ER PHAGOSOME PATHWAY
1.99e-03 2.12e-01 INWARDLY RECTIFYING K CHANNELS
3.12e-03 2.75e-01 ANTIGEN PROCESSING CROSS PRESENTATION
7.49e-03 6.36e-01 ANTIGEN PROCESSING CROSS PRESENTATION
8.38e-03 6.97e-01 IRON UPTAKE AND TRANSPORT

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
4.69e-07 4.99e-03 abnormal renal water transport

1.89e-05 7.30e-02 decreased urine osmolality

2.02e-05 7.65e-02 abnormal fluid regulation

2.80e-05 9.84e-02 increased blood osmolality

1.56e-04 3.02e-01 thymus cortex hypoplasia

2.11e-04 3.59e-01 defective assembly of class I molecules

3.09e-04 4.57e-01 increased circulating triglyceride level

3.78e-04 5.17e-01 decreased level of surface class I molecules

5.95e-04 6.72e-01 absent CD8-positive, alpha-beta T cells

1.40e-03 1.00e+00 abnormal blood-brain barrier function

1.87e-03 1.00e+00 retinal ischemia

1.87e-03 1.00e+00 unilateral deafness

2.11e-03 1.00e+00 dehydration

2.44e-03 1.00e+00 decreased cholesterol level

3.02e-03 1.00e+00 increased insulin secretion

3.25e-03 1.00e+00 abnormal erythrocyte osmotic lysis

3.76e-03 1.00e+00 increased physiological sensitivity to xenobiotic

4.38e-03 1.00e+00 hypoglycemia

4.50e-03 1.00e+00 abnormal spleen red pulp morphology

5.61e-03 1.00e+00 stomatocytosis


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:33:29 2018 - R2HTML